Loading
A US government health research programme that aims to build one low-cost radiotherapy treatment able to work against cancer that has spread as well as cancer in one place, by combining very fast radiotherapy with materials placed in the tumour that rouse the immune system. It is at the stage of choosing who to fund.
ARPA-H's programme page frames 1-CURE around the question of whether radiotherapy technology could enable one low-cost curative treatment effective for all cancers. It states that curative radiotherapy is feasible only for some localised tumours and is ineffective against metastatic disease, and that the programme will develop a single, rapid, low-cost and accessible approach for local, metastatic and radiotherapy-resistant cancers. Its two named components are multifunctional smart radiotherapy biomaterials, which enable image-guided targeting and sustained delivery of immune adjuvants, and an Abscopal Treatment Planning System that integrates those biomaterials with ultra-high dose rate (FLASH) radiotherapy to achieve abscopal responses, in which irradiating one tumour leads the immune system to attack others. The programme manager named on the page is Wilfred Ngwa. As read on 4 November 2026, ARPA-H was reviewing proposals and no longer accepting submissions, with awards to be announced after negotiation.
Shares Most of the world has almost no cancer care and the tag research-funding.
Shares Most of the world has almost no cancer care and the tag research-funding.
Shares Most of the world has almost no cancer care and the tag research-funding.
Shares Advanced Research Projects Agency for Health and the tag research-funding.
Shares Surgery and radiotherapy cure most, get least, Most of the world has almost no cancer care.
Shares Surgery and radiotherapy cure most, get least, Most of the world has almost no cancer care.
Shares Surgery and radiotherapy cure most, get least, Most of the world has almost no cancer care.
Shares Surgery and radiotherapy cure most, get least, Most of the world has almost no cancer care.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/